Whilst we still have a period of time before the pending quarterly activity report i am keen to hear what other 'shareholders' believe the report will yield in regards to the participation numbers, future timelines and the progress of the HER2 Breast Cancer study in general. Wishing you all a safe and prosperous 2022.
Predictions On The Upcoming Quarterly
Add IBX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| IBX (ASX) Chart |
Day chart unavailable